The efficacy and safety of Apatinib combined with TACE in the treatment of hepatocellular carcinoma: a meta-analysis

被引：0
|
作者：
Anan Gong
Xiaofei Li
机构：
[1] YiWu Central Hospital,Department of Hepatobiliary Surgery
[2] YiWu Central Hospital,Department of Infectious Diseases
来源：
World Journal of Surgical Oncology | / 20卷
关键词：
Apatinib; TACE; Liver; Cancer; Treatment; Effect; Safety; Review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] RETRACTED: Comparison of Efficacy and Safety of TACE Combined with Microwave Ablation and TACE Combined with Cryoablation in the Treatment of Large Hepatocellular Carcinoma (Retracted Article)
    Wang, Yujia
    Li, Wei
    Man, Wenling
    Dong, Xiaolin
    Luo, Yinghao
    Zhang, Yan
    Zhang, Yongchuang
    Dong, Chang
    Sun, Weiwei
    Yang, Po
    COMPUTATIONAL INTELLIGENCE AND NEUROSCIENCE, 2022, 2022
  • [22] TACE combined with apatinib for the treatment of BCLC stage C of hepatocellular carcinoma: A restrospective controlled study
    Kan, Xuefeng
    Xiong, Bin
    Wang, Yong
    Liang, Bin
    Zhou, Guofeng
    Zheng, Chuansheng
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [23] TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysis
    He, Guangzhi
    Zheng, Chenhong
    Huo, Huiping
    Zhang, Huiming
    Zhu, Zhiquan
    Li, Junlai
    Zhang, Hongpeng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 40 : 436 - 442
  • [24] The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma
    Liu, Shun
    Liu, Kai-Cai
    Lv, Wei-Fu
    Lu, Dong
    Zhu, Xian-Hai
    Jiang, Bo
    Tan, Yu-Lin
    Wang, Guo-Xiang
    FRONTIERS IN MEDICINE, 2021, 8
  • [25] Comparison of efficacy between TACE combined with apatinib and TACE alone in the treatment of intermediate and advanced hepatocellular carcinoma: A single-center randomized controlled trial
    Lu, Wei
    Jin, Xin-Li
    Yang, Chao
    Du, Peng
    Jiang, Fu-Qiang
    Ma, Jun-Peng
    Yang, Jian
    Xie, Peng
    Zhang, Zhe
    CANCER BIOLOGY & THERAPY, 2017, 18 (06) : 433 - 438
  • [26] Efficacy of camrelizumab and apatinib combination therapy versus apatinib only in treatment of advanced hepatocellular carcinoma: A meta-analysis.
    Swed, Sarya
    Motawea, Karam R.
    AbdelQadir, Yossef Hassan
    Gamal, Mohamed
    El-Sakka, Amro A.
    Kandil, Omneya A.
    Abdelazeem, Basel
    Abdelaziz, Muhammad
    Wahsh, Engy A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16147 - E16147
  • [27] The efficacy and safety of apatinib for refractory malignancies: a review and meta-analysis
    Sun, Dantong
    Hou, Helei
    Zhang, Chuantao
    Zhang, Xiaochun
    ONCOTARGETS AND THERAPY, 2018, 11 : 6539 - 6554
  • [28] The long-term efficacy and safety of apatinib are inferior to sorafenib in the first-line treatment of advanced hepatocellular carcinoma: A systematic review and meta-analysis
    Li, Dailong
    Zhang, Chunzhen
    Yang, Kui
    Ma, Zhiwei
    Ma, Lili
    Cheng, Chunlai
    Xu, Lu
    Wan, Sha
    MEDICINE, 2024, 103 (03) : E36865
  • [29] Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis
    Yan, Lun-Jie
    Yao, Sheng-Yu
    Li, Hai-Chao
    Meng, Guang-Xiao
    Liu, Kai-Xuan
    Ding, Zi-Niu
    Hong, Jian-Guo
    Chen, Zhi-Qiang
    Dong, Zhao-Ru
    Li, Tao
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (05) : 835 - 846
  • [30] Efficacy and Safety of TACE Combined with a Tyrosine Kinase Inhibitor for the Treatment of TACE-Refractory Hepatocellular Carcinoma: A Retrospective Comparative Study
    Chen, Yu-Xing
    Zhang, Jin-Xing
    Zhou, Chun-Gao
    Liu, Jin
    Liu, Sheng
    Shi, Hai-Bin
    Zu, Qing-Quan
    Cheng, Yuan
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (02) : 924 - 931
12345